Bank of New York Mellon’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$426K Buy
111,341
+410
+0.4% +$1.57K ﹤0.01% 3576
2025
Q1
$638K Sell
110,931
-5,847
-5% -$33.6K ﹤0.01% 3309
2024
Q4
$583K Sell
116,778
-1,308
-1% -$6.53K ﹤0.01% 3422
2024
Q3
$636K Sell
118,086
-77,636
-40% -$418K ﹤0.01% 3370
2024
Q2
$648K Buy
195,722
+34,885
+22% +$115K ﹤0.01% 3428
2024
Q1
$526K Sell
160,837
-9,202
-5% -$30.1K ﹤0.01% 3491
2023
Q4
$597K Sell
170,039
-7,324
-4% -$25.7K ﹤0.01% 3456
2023
Q3
$1.18M Sell
177,363
-234
-0.1% -$1.56K ﹤0.01% 3061
2023
Q2
$1.49M Buy
177,597
+111,294
+168% +$934K ﹤0.01% 2988
2023
Q1
$658K Buy
66,303
+263
+0.4% +$2.61K ﹤0.01% 3340
2022
Q4
$460K Sell
66,040
-182
-0.3% -$1.27K ﹤0.01% 3576
2022
Q3
$354K Sell
66,222
-12,253
-16% -$65.5K ﹤0.01% 3753
2022
Q2
$314K Sell
78,475
-131,340
-63% -$526K ﹤0.01% 3851
2022
Q1
$932K Buy
209,815
+22,748
+12% +$101K ﹤0.01% 3359
2021
Q4
$749K Buy
187,067
+3,258
+2% +$13K ﹤0.01% 3555
2021
Q3
$1.61M Sell
183,809
-38,192
-17% -$335K ﹤0.01% 3117
2021
Q2
$2.52M Buy
222,001
+174,647
+369% +$1.98M ﹤0.01% 2847
2021
Q1
$563K Sell
47,354
-9,320
-16% -$111K ﹤0.01% 3618
2020
Q4
$388K Buy
56,674
+41,126
+265% +$282K ﹤0.01% 3732
2020
Q3
$115K Hold
15,548
﹤0.01% 3936
2020
Q2
$65K Sell
15,548
-51,246
-77% -$214K ﹤0.01% 3948
2020
Q1
$165K Sell
66,794
-7,463
-10% -$18.4K ﹤0.01% 3788
2019
Q4
$431K Sell
74,257
-3,290
-4% -$19.1K ﹤0.01% 3659
2019
Q3
$409K Buy
77,547
+2,194
+3% +$11.6K ﹤0.01% 3647
2019
Q2
$452K Buy
75,353
+5,406
+8% +$32.4K ﹤0.01% 3647
2019
Q1
$631K Sell
69,947
-69,358
-50% -$626K ﹤0.01% 3433
2018
Q4
$1.16M Buy
139,305
+9,290
+7% +$77.1K ﹤0.01% 3021
2018
Q3
$1.8M Buy
130,015
+80,173
+161% +$1.11M ﹤0.01% 2901
2018
Q2
$396K Buy
49,842
+29,051
+140% +$231K ﹤0.01% 3727
2018
Q1
$156K Buy
20,791
+2,413
+13% +$18.1K ﹤0.01% 3967
2017
Q4
$125K Sell
18,378
-192
-1% -$1.31K ﹤0.01% 4021
2017
Q3
$134K Buy
+18,570
New +$134K ﹤0.01% 3948